This compound is primarily utilized in the field of pharmaceutical research, particularly in the development of central nervous system (CNS) drugs. It acts as a key intermediate in the synthesis of compounds targeting neurological disorders such as Parkinson's disease, schizophrenia, and depression. Its structure allows it to interact with dopamine receptors, making it valuable for studying receptor modulation and designing potential therapeutic agents. Additionally, it is employed in preclinical studies to explore its efficacy and safety profile for treating neurodegenerative conditions. Researchers also investigate its potential in pain management due to its interaction with neurotransmitter systems involved in pain perception.